Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Emily, Zhu"'
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 41, Iss , Pp 101148- (2024)
Many adults with phenylketonuria (PKU) were discharged from clinics before lifelong treatment guidelines and new therapies. As part of the PKU lost to clinical care study, moderated focus groups were conducted to understand why individuals become los
Externí odkaz:
https://doaj.org/article/52920ab5d8724bce922ce9b9a78c7e54
Autor:
Roberta Venturella, Tomasz Rechberger, János Zatik, Rachel B. Wagman, Emily Zhu, Viatcheslav G. Rakov, Felice Petraglia
Publikováno v:
Gynecological Endocrinology, Vol 39, Iss 1 (2023)
Objective In the 24-week, phase 3 LIBERTY 1 (L1) and LIBERTY 2 (L2) trials, relugolix combination therapy (relugolix-CT (relugolix 40 mg, estradiol 1 mg, norethisterone acetate 0.5 mg)) reduced uterine fibroid (UF)-associated symptoms. This post hoc
Externí odkaz:
https://doaj.org/article/76f07f8c72ad4f85875ac4b41b5da431
Publikováno v:
In Transportation Research Part C March 2022 136
Autor:
Himani Aggarwal, Kerigo Ndirangu, Katherine B Winfree, Catherine Elizabeth Muehlenbein, Emily Zhu, Vanita Tongbram, Howard Thom
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 2 (2023)
Introduction: In the absence of head-to-head trials comparing immunotherapies for advanced nonsquamous non-small-cell lung cancer (NsqNSCLC), a network meta-analysis (NMA) was conducted to compare the relative efficacy of these treatments. Material
Externí odkaz:
https://doaj.org/article/3d55849932a942438273d8c2ed031e88
Publikováno v:
In Transportation Research Part E December 2020 144
Autor:
Fainman, Emily Zhu, Kucukyazici, Beste
Publikováno v:
In Socio-Economic Planning Sciences December 2020 72
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Contradictory and limited data are available about the presentation and outcomes of patients with RET-fusion positive metastatic NSCLC as compared to patients without RET fusions. This observational study utilizing a linked electr
Externí odkaz:
https://doaj.org/article/95b5c13d67c04b14a7eaf97e2fbb541c
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/4ca5219bfe7c49f3a109df33d14c5dfd
Autor:
Himani Aggarwal, KayOnda Bayo, Yimei Han, Catherine Elizabeth Muehlenbein, Yajun Emily Zhu, Jong Seok Kim
Publikováno v:
Immunotherapy. 15:267-281
Aim: To evaluate treatment patterns and overall survival (OS) in real world metastatic non-squamous non-small-cell lung cancer (NSQ-NSCLC) patients that received pembrolizumab plus pemetrexed-platinum (pembro+pem+plat) aligned with KEYNOTE-189. Mater
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1f17ce5122a081836079b2e2b9256c2
https://doi.org/10.2217/imt-2022-0166
https://doi.org/10.2217/imt-2022-0166
Publikováno v:
Global Health Action, Vol 13, Iss 1 (2020)
The Coronavirus Disease 2019 (COVID-19) pandemic has overwhelmed many health systems globally. Innovative initiatives are needed to combat the pandemic and scaleup response efforts. This communication describes a collaborative partnership between an
Externí odkaz:
https://doaj.org/article/941e72b35aee482b98180450d3be944b